title: Prescription compliance or illicit designer drug abuse?
authors.affiliation: Department of Laboratory Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA 94110, USA. Matthew.S.Petrie@kp.org
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Petrie
authors.forename: Kara L
authors.initials: KL
authors.lastname: Lynch
authors.forename: Alan H B
authors.initials: AH
authors.lastname: Wu
authors.forename: Angela A
authors.initials: AA
authors.lastname: Steinhardt
authors.forename: Gary L
authors.initials: GL
authors.lastname: Horowitz
mesh_terms: D019969:Amphetamine-Related Disorders / Q000175:diagnosis*; D000928:Antidepressive Agents / Q000652:urine*; D016642:Bupropion / Q000652:urine; D003429:Cross Reactions; D015198:Designer Drugs / Q000032:analysis*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D007118:Immunoassay; D055118:Medication Adherence; D008875:Middle Aged; D010879:Piperazines / Q000652:urine*; D014196:Trazodone / Q000652:urine*
chemical_list: D000928:Antidepressive Agents; D015198:Designer Drugs; D010879:Piperazines; D016642:Bupropion; C015068:1-(3-chlorophenyl)piperazine; D014196:Trazodone